From Root to Ritual

A study of over 1,500 participants found hair quality satisfaction highest in people who wash 5-6 times per week. A review medically approved by the American Hair Loss Association in April 2026 found that for people with AGA, infrequent washing can lead to sebum buildup, increased inflammation, microbial imbalance, and oxidative stress — all of which may accelerate follicular miniaturisation. The "no-poo" movement has it backwards for people with hair loss. Here is the evidence-based answer — with the honest exceptions.

Scalp pain, tenderness, or burning at the hair root — especially during active shedding — has a medical name: trichodynia. It affects approximately one-third of patients with trichological disorders and is significantly more common in women. A January 2025 study found tissue substance P levels 5x higher in trichodynia AGA patients vs controls. A June 2026 study found botulinum toxin relieved it in 9 out of 10 treatment-resistant cases. And a 2025 JDIN study confirmed scalp pain location offers diagnostic clues about which type of hair loss you have. Here is the complete picture.

Thyroid disorders affect up to 50% of patients with hair loss, per the British Journal of Dermatology. A 2025 study of 100 women with hair loss vs 100 controls found TSH and free T4 were significantly lower in the hair loss group — both within normal range. TSH-only testing misses T3 conversion problems. Biotin supplements interfere with thyroid test results. And the outer eyebrow sign is more sensitive than any blood test for early thyroid hair loss. Here is the complete picture.

Iron deficiency affects approximately 72% of women experiencing hair loss — making it the most common nutritional cause. Standard labs flag deficiency at 12-15 ng/mL. The hair-optimal ferritin target is 40-70 ng/mL. Women with ferritin at or below 30 ng/mL have 21 times higher odds of telogen effluvium vs those above. And ferritin is an acute-phase reactant — inflammation can falsely inflate it, masking true depletion. Here is what your ferritin result actually means for your hair.

Central centrifugal cicatricial alopecia (CCCA) affects 2.7-5.7% of Black women and is the most common scarring alopecia in this population. A February 2026 UCLA study published in JDIN found CCCA has the longest time to diagnosis of any scarring alopecia — a health disparity with direct consequences, since scarred follicles cannot be restored. A May 2025 Mayo Clinic case-control study of 54 patients confirmed CCCA patients are significantly less likely to improve with treatment than other scarring alopecias. Here is what to know, and why early recognition changes everything.

A November 2025 cross-sectional study in Healthcare (Liran et al.) found that patients with hair loss had slightly lower zinc levels than controls — but the difference was minor, within the normal range, and not clinically significant. The study concluded that routine zinc testing is not recommended when evaluating hair loss. And yet zinc genuinely matters in alopecia areata and telogen effluvium. And excess zinc causes hair loss by interfering with iron. Here is the honest picture.

A 2009 study of 823 women confirmed that the highest percentage of telogen-phase hairs occurs in summer — meaning more hairs are in the resting phase right now, in late July. Three to four months from now, those hairs shed. The autumn shed is documented, it is biological, and it follows a predictable annual rhythm. Here is the science behind it, how to tell if yours is seasonal or something else, and the one thing that changes whether the shed is mild or significant.

This week covered seven ingredients — bhringaraj, ginger, rosemary, saw palmetto, nettle, scalp massage, vitamin D. A lot of science. This Sunday is not science. It is the thing underneath all of it: what actually changes when you stop approaching your hair as a problem to be solved and start approaching it as a signal worth understanding. Three months into this series — here is the shift that makes everything else work better.

Stinging nettle (Urtica dioica) has been used in hair care across cultures for centuries — but until recently, the mechanism was more traditional wisdom than confirmed science. A 2023 in vitro study confirmed that nettle leaf extract significantly downregulates 5-alpha reductase type II gene expression. A 2025 computational study identified six compounds in nettle with strong binding affinity to the same enzyme. Here is what nettle does for hair — and the honest difference between what the lab confirms and what clinical trials haven't yet fully established.

A standardised scalp massage of four minutes daily for 24 weeks produced measurably thicker hair compared to a control group that received no massage. No product. No supplement. No prescription. Just four minutes of consistent daily pressure applied with the fingertips. Here is what the trial found, the three mechanisms behind it, and the exact technique worth adopting this summer.

A 2015 randomized comparative trial found rosemary oil matched minoxidil 2% for hair count at 6 months — with significantly less scalp itching. That result is real. But there are three things the citations usually leave out: the comparison was to 2% minoxidil, not the 5% commonly prescribed today. Neither group saw significant results at 3 months — only at 6. And a fresh double-blind RCT (Rosmagain™) now shows 57.73% hair growth rate improvement and 68.70% thickness increase vs placebo. Here is the complete picture.

Saw palmetto (Serenoa repens) inhibits 5-alpha reductase — the same enzyme as finasteride — but at 30-40% compared to finasteride's 70% and dutasteride's 98%. A 2025 RCT showed significant improvement in hair density and quality. A 2026 180-day extension confirmed continued improvement with no adverse events. Here is the complete honest picture — what saw palmetto does, how it compares to pharmaceutical options, who it's enough for, and who needs something stronger.